BELLANTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 6.492
NA - Nord America 5.852
AS - Asia 4.118
SA - Sud America 524
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 8
Totale 17.085
Nazione #
US - Stati Uniti d'America 5.740
SG - Singapore 1.463
CN - Cina 1.377
IE - Irlanda 1.356
IT - Italia 1.332
RU - Federazione Russa 834
UA - Ucraina 812
SE - Svezia 730
BR - Brasile 439
HK - Hong Kong 383
FR - Francia 377
DE - Germania 357
FI - Finlandia 237
IN - India 231
VN - Vietnam 227
TR - Turchia 174
GB - Regno Unito 143
AT - Austria 78
CA - Canada 57
NL - Olanda 38
BD - Bangladesh 37
MX - Messico 36
BE - Belgio 33
ES - Italia 33
PL - Polonia 33
AR - Argentina 30
CZ - Repubblica Ceca 28
JP - Giappone 28
IQ - Iraq 27
ID - Indonesia 25
ZA - Sudafrica 25
AE - Emirati Arabi Uniti 19
EU - Europa 18
PK - Pakistan 18
SA - Arabia Saudita 15
CH - Svizzera 13
CO - Colombia 11
IR - Iran 11
KR - Corea 11
VE - Venezuela 11
CL - Cile 10
EC - Ecuador 10
LT - Lituania 10
UZ - Uzbekistan 10
JO - Giordania 9
KE - Kenya 9
AL - Albania 8
PH - Filippine 8
TN - Tunisia 8
EG - Egitto 7
KZ - Kazakistan 7
RO - Romania 7
IL - Israele 6
MA - Marocco 6
HU - Ungheria 5
MY - Malesia 5
PY - Paraguay 5
RS - Serbia 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
JM - Giamaica 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
GR - Grecia 3
HN - Honduras 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
MT - Malta 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
GA - Gabon 1
GT - Guatemala 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
Totale 17.072
Città #
Dublin 1.356
San Jose 950
Singapore 735
Chandler 648
Jacksonville 552
Nyköping 482
Ashburn 394
Hong Kong 376
Dearborn 342
Beijing 297
Dallas 271
Nanjing 238
Santa Clara 211
Lauterbourg 157
Wilmington 152
New York 137
Princeton 133
Nanchang 114
Munich 110
Moscow 108
Helsinki 105
Rome 98
San Mateo 95
Ho Chi Minh City 93
Ann Arbor 91
The Dalles 90
Boardman 72
Vienna 72
Milan 68
Shenyang 64
Bari 63
Foggia 57
Woodbridge 54
Tianjin 53
Los Angeles 49
Kunming 46
São Paulo 45
Hebei 41
Turku 41
Hanoi 39
Jiaxing 36
Des Moines 34
Brussels 33
Changsha 32
Frankfurt am Main 32
Hangzhou 32
Jinan 30
Houston 27
Stevenage 27
Toronto 26
Shanghai 25
Delhi 24
Redwood City 24
Council Bluffs 23
Tokyo 23
Zhengzhou 23
London 22
Naples 22
Ningbo 22
Seattle 22
Brno 20
Guangzhou 20
Hilden 19
Warsaw 18
Florence 17
Pune 17
Rio de Janeiro 17
Assago 16
San Francisco 16
Brooklyn 15
Chennai 14
Jakarta 14
Norwalk 14
Palermo 14
Bologna 13
Caserta 13
Hillsboro 13
Mola Di Bari 13
Orem 13
Wuhan 13
Atlanta 12
Belo Horizonte 12
Fuzhou 12
Baghdad 11
Barcelona 11
Chicago 11
Haiphong 11
Paris 11
San Severo 11
Johannesburg 10
Kraków 10
Montreal 10
Orange 10
Padova 10
Taizhou 10
Augusta 9
Charlotte 9
Nairobi 9
Stockholm 9
Tashkent 9
Totale 10.154
Nome #
Effetti della sarcopenia e dell’obesità sarcopenica sul rischio cardiovascolare 813
Effetti dell’associazione tra malnutrizione e sarcopenia sulla composizione corporea 272
A silybin-phospholipid vitamin E complex (siliphos) limits the hepatic damage and reduces oxidative stress in human obesity – related liver disease. 204
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 199
A silybin-phospholipid-vitamin E complex (SILIPHOS) prevents oxidation of UCP2 and limits mitochondrial dysfunction during non-alcoholic steatohepatitis. 193
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 179
Effetti del diabete mellito tipo 2 sulla composizione corporea dei pazienti sarcopenici 173
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 164
Alteration of fatty acid beta-oxidation observed in severe steatosis depends on CPT1 impairment and change in mitochondrial membrane lipid composition. 163
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 160
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 160
Adherence to Mediterranean Diet, Malnutrition, Length of Stay and Mortality in Elderly Patients Hospitalized in Internal Medicine Wards 157
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis 154
Meccanismi del danno ed effetti protettivi di exenatide in un modello sperimentale di ischemia/riperfusione cerebrale 153
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 149
A Silybin-phospholipid Complex Prevents Mitochondrial Oxidative Stress in Models of Chronic Liver Disease. 147
UCP2 overexpression sensitizes NASH liver to ischemia/reperfusion injury by increasing mitochondrial proton leak. 147
Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model 147
Il complesso silibina-fosfolipidi-vitamina E normalizza l’ipertransaminasemia in soggetti affetti da steatosi epatica non alcolica. 145
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury 144
A silybin-phospholipids-vitamin E complex (siliphos) reduces oxidative stress in patients affected by non-alcoholic hepatic steatosis. 143
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 140
Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity (Q1 WoS) 140
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 139
A silybin-phospholipid-vitamin E complex reduces mitochondrial oxidative stress in a rodent model of chronic cholestasis. 136
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 136
Analisi della bioenergetica mitocondriale in corso di Ischemia/Riperfusione renale e ruolo protettivo del postcondizionamento ischemico. 134
N-acetylcysteine prevents amiodarone-induced inhibition of Complex I, OXPHOS uncoupling and cardiolipin peroxidation in rat liver mitochondria. 134
Alterazioni bioenergetiche mitocondriali durante lo sviluppo della Steatoepatite Non Alcolica 132
Oxidative stress and aging. 132
Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart 131
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 130
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 128
Exenatide e gli inibitori di DPP-4 sono efficaci nel trattamento della neuropatia sensitiva associata a diabete mellito tipo II in pazienti anziani 128
Oxidation of Carnitine Palmitoyl Transferase 1 alters fatty acid metabolism in a rodent model of nonalcoholic steatohepatitis. 127
Mitochondria peroxide synthesis and CPT-1 nitrosylation durino NASH development: a model of oxidative stress disease 127
CPT-1 is a key target of mitochondria nitrosylation during NASH development 127
UCP2 induces mitochondrial uncoupling during nonalcoholic steatohepatitis: An adaptative mechanism to reduce oxidative stress but producing depletion of ATP 127
UCP2 increase the sensibilità to liver ischemia/reperfusion injury in a NASH model. 127
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 127
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 125
Mitochondrial Oxidative Stress is an Early Event in Amiodarone Hepatotoxicity, Inducing Complex I Impairment and Cardiolipin Peroxidation. 124
Alterazioni della bioenergetica mitocondriale in un modello animale di ipoperfusione cerebrale cronica. 124
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema 124
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 123
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 123
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 123
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 122
Disfunzione mitocondriale in differenti aree cerebrali in un modello transgenico di Alzheimer. 122
Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet. 121
Il postcondizionamento renale protegge il rene dal danno da ischemia riperfusione attraverso l’inibizione del mitchondrial permeabilità transitino pore. 120
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 120
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 120
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 119
Polimorfismi del gene della Glutatione S-Trasferasi Omega -1: analisi del linkage disequilibrium fra i polimorfismi Ala140Asp E Glu155ΔGlu dell’esone 4 e interazione con l’ApoE in una popolazione di centenari pugliesi 118
Cerebral oligoemia induces mitochondria dysfunction and increase in hydroperoxide production in a chronic rat model of vascular dementia. 117
UCP2 increase the sensibility to liver ischemia/reperfusion injury in a NASH model. 116
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 115
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 114
Nella steatoepatite indotta da amiodarone le alterazioni della funzione mitocondriale precedono la steatosi e la necrosi e suggeriscono nuove strategie di intervento terapeutico. 112
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 112
Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1α activation in hepatic ischemia/reperfusion injury (Q1 WoS) 111
Reactive Oxygen Species (ROS) and liver disease therapy 110
Studio delle alterazioni comportamentali e istologiche in un modello animale di oligoemia cerebrale cronica. 109
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease 109
Changes in circulating redox bilance and increased markers of oxidative stress predict Frailty condition: the “Oxidative Frailty Syndrome”. 108
Rat brain bioenergetics is impaired in a two-vessel occlusion model of vascular dementia. 107
Oxidative stress and mitochondrial dysfunction are associated with the opening of permeability transition pore in a rodent model of NAFLD. 107
Oxysterols in the orchestra of liver cell metabolism 107
Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients 106
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell'assessment bioenergetico. 105
Mitochondrial involvement in non-alcoholic steatohepatitis 104
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 103
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 103
NASH induces expression of UCP2 and mitochondria respiratory impairment in liver hepatocytes 102
Mitochondrial activity in NASH pathogenesis: role of respiratory chain and fatty acids transport 102
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 102
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 102
Mitochondrial proton leak during aging: ditferent effect on free radicals production in mitotic and postmitotic tissues. 100
Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management 100
Treatment of chronic HCV infection in the era of protease inhibitors 99
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 99
Changes in circulating redox balance and increased markers of oxidative stress predict Frailty condition: the "Oxidative Frailty Syndrome'' 97
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell’assessment bioenergetico. 96
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-RIPERFUSION INJURY 96
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-REPERFUSION INJURY 95
Blood Magnesium Level and Selected Oxidative Stress Indices in Lead-Exposed Workers 94
An Amino Acid Mixture to Counteract Skeletal Muscle Atrophy: Impact on Mitochondrial Bioenergetics (Q1 WoS) 93
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress 92
HNE induces UCP2 expression and proton leak to limit oxidative stress but reduces ATP synthesis in non-alcoholic steatohepatitis. 91
Free radical biology for medicine: learning from nonalcoholic fatty liver disease. 91
Renal postconditioning: a novel mechanism in the prevention of I/R damage. 90
Effect of sevoflurane and propofol anaesthesia on mitochondria and postoperative hepatocellular injury in steatotic patients: preliminary data: 9AP5‐7 90
Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. 90
Mitochondrial dysfunction in nonalcoholic steatohepatitis. 89
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 87
Targeting Mitochondria: a new promising approach for the treatment of liver diseases 86
Reliability of serum procalcitonin concentration for the diagnosis of sepsis in elderly patient with chronic kidney disease 86
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 86
An open-label, single-center pilot study to test the effects of an amino acid mixture in older patients admitted to internal medicine wards 86
Totale 13.012
Categoria #
all - tutte 86.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 186 12 34
2021/20221.030 119 12 23 16 98 40 51 110 123 102 83 253
2022/20233.270 331 171 151 157 176 280 40 265 1.501 35 65 98
2023/2024807 96 44 38 47 47 213 29 43 13 18 56 163
2024/20252.905 161 76 122 134 130 350 293 138 680 188 311 322
2025/20264.865 353 357 586 624 353 240 1.176 610 304 262 0 0
Totale 17.728